BioTechne
Open
$56.12
Prev. Close
$56.12
High
$56.18
Low
$55.95
Market Snapshot
$8.77B
80.0
1.00
$1.2B
Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for research and clinical diagnostic communities. The company is headquartered in Minneapolis, Minnesota and currently employs 3,100 full-time employees. The Company’s segments include Protein Sciences segment and Diagnostics and Spatial Biology segment. The Protein Sciences segment is a developer and manufacturer of purified proteins and reagent solutions, most notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents and T-Cell activation technologies. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products, including controls, calibrators, blood gas and clinical chemistry controls and other reagents for OEM and clinical customers. This segment also manufactures and sells fully automated multiomic spatial biology instrumentation and advanced tissue-based in-situ hybridization assays (ISH) for research and clinical use.
BioTechne continues to advance in the biotech sector, developing innovative solutions and maintaining a strong position amid increasing interest in AI-enhanced technologies and applications.
Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for research and clinical diagnostic communities. The company is headquartered in Minneapolis, Minnesota and currently employs 3,100 full-time employees. The Company’s segments include Protein Sciences segment and Diagnostics and Spatial Biology segment. The Protein Sciences segment is a developer and manufacturer of purified proteins and reagent solutions, most notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents and T-Cell activation technologies. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products, including controls, calibrators, blood gas and clinical chemistry controls and other reagents for OEM and clinical customers. This segment also manufactures and sells fully automated multiomic spatial biology instrumentation and advanced tissue-based in-situ hybridization assays (ISH) for research and clinical use.
Recently from Cashu

Bio-Techne Partners with Refeyn to Transform Antibody Analysis in Biotech Research
Earlier this week, Bio-Techne (Ticker: TECH) and Refeyn announced a transformative partnership aimed at revolutionizing the characterization process of bispecific antibodies and biosimilars in biotech…

Bio-Techne Introduces Advanced Workflow for Bispecific Antibody and Biosimilar Characterization
Bio-Techne (Ticker: TECH) unveils a groundbreaking workflow aimed at transforming the characterization of bispecific antibodies and biosimilars. This innovative approach combines Bio-Techne's R&D Syst…
Bio-Techne Engages Investors at Upcoming Healthcare Conferences to Showcase Innovations
Bio-Techne Reinforces Commitment to Life Sciences Through Upcoming Conferences Bio-Techne Corporation, a prominent player in the global life sciences industry, actively engages with the investment com…
Bio‑Techne posts flat revenue, stronger margins via cost programs and Asia expansion
Stabilizing sales and stronger margins underpin Bio‑Techne’s near-term strategy Bio‑Techne posts a quarter of steady revenue and improving profitability as it leans on cost programs and regional execu…